Top Markets
Coin of the day
Zhejiang Xinguang Pharmaceutical Co., Ltd. Zhejiang Xinguang Pharmaceutical Co., Ltd.

Zhejiang Xinguang Pharmaceutical Co., Ltd.

300519
Rank in Stocks #15627
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and... Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China.
Share Price
$2.13
Market Cap
$341.30M
Change (1 day)
1.66%
Change (1 year)
-8.53%
Country
CN
Trade Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519)

Category

P/E ratio for Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519)
P/E ratio as of 2026 TTM: 0
According to Zhejiang Xinguang Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Zhejiang Xinguang Pharmaceutical Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.